Clinical trial enrollment is vital for advancing renal cell carcinoma treatment, providing access to innovative therapies and potentially better care. The STELLAR-002 study evaluated zanzalintinib ...
Researchers at London Health Sciences Center Research Institute (LHSCRI) have launched a Phase II clinical trial that aims to ...
6don MSN
Recurrent UTIs a sign of kidney cancer: Silent symptoms, hidden risks, and when to see a doctor
Recurrent urinary tract infections could signal kidney cancer. This disease often progresses without clear symptoms. Early ...
Kidney cancer is on the verge of becoming a far larger health problem than it currently is, with cases expected to nearly ...
The powerhouse drug Avastin may be linked to severe kidney problems. June 11, 2010 -- Patients taking the anti-cancer drug Avastin may increase their risk of kidney damage, a new study says -- but ...
Modifiable risk factors such as obesity, smoking, lack of exercise, diabetes and hypertension are projected to be one of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback